Research and Markets: Market Research - Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/l69r5q/global_rheumatoid) has announced the addition of the "Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)" report to their offering.

Rheumatoid arthritis (RA) is a chronic inflammatory disorder that principally attacks synovial joints. It is one of the most common autoimmune diseases affecting people of all ages and races. RA affects the lining of joints, causing a painful swelling that can eventually result in bone erosion and joint deformity. It also leads to stiffness, and redness in the joints. The main factor causing rheumatoid arthritis remains unknown. However, according to studies around the world some of the genetic and environmental factors are found to be more probable causers.

Treatment of Rheumatoid Arthritis involves frequent drugs administration as RA is a progressive and incurable disease. Drugs used for treatment of RA are classified as first line agents- consisting of non steroidal anti-inflammatory drugs (NSAIDs) and steroids such as glucocorticoids and second line agents- consisting of disease modifying anti-rheumatic drugs such as chloroquine, gold salts, penicillamine, cyclosporine, and several biological agents like TNF-a and interleukin-1 inhibitors.

This report titled 'Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)' provides an in-depth analysis of global rheumatoid arthritis market with special focus on biologics drugs.

The study assesses the key opportunities and underlying trends in the market and outlines the factors that are and will continue to drive growth of the industry in the forecasted period (2013-18). Further, key drug manufacturers of the global rheumatoid arthritis market such as Abbvie Inc. (Humira), Amgen Inc. (Enbrel), Johnson & Johnson (Remicade), Roche Holdings AG (Actemra) are profiled in the report.

Company Coverage

- Abbvie Inc.

- Amgen Inc.

- Johnson & Johnson

- Roche Holdings AG

Key Topics Covered:

1. Executive Summary

2. Rheumatoid Arthritis: An Introduction

3. Rheumatoid Arthritis Treatment

4. Global Rheumatoid Arthritis Market Analysis

5. Global Rheumatoid Arthritis Drug Market Analysis

6. Global Rheumatoid Arthritis Market: Growth Drivers & Challenges

7. Global Rheumatoid Arthritis Market Trends

8. Global Rheumatoid Arthritis Market: Competitive Landscape

9. Company Analysis: Global Rheumatoid Arthritis Market

List of Figures

List of Tables

For more information visit http://www.researchandmarkets.com/research/l69r5q/global_rheumatoid

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals